Company Description
NanoVici is a bio-pharmaceutical company formed to commercialize targeted nanotherapeutics licensed from Emory University and Georgia Tech.
NanoVici, is an Atlanta-based biopharmaceutical company formed to commercialize targeted nanotherapeutics licensed from Emory University and Georgia Tech. Their lead therapeutic candidate, NV-111, targets folic acid receptive cancers, representing 28% of all solid tumor cancers and a $10 billion worldwide market. In university lab tests repeated with very consistent results, NV-111 completely destroys cancer tumors with folate receptors.
-
Manufacturer:
Science and Engineering -
Company Website:
-
Company E-mail:
-
Company Address:
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits